SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-171457
Filing Date
2018-05-23
Accepted
2018-05-23 08:30:33
Documents
12
Period of Report
2018-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d593778d8k.htm 8-K 15263
2 EX-99.1 d593778dex991.htm EX-99.1 20350
3 EX-99.2 d593778dex992.htm EX-99.2 9701
4 GRAPHIC g593778ex99_2s1g1.jpg GRAPHIC 152285
5 GRAPHIC g593778ex99_2s2g1.jpg GRAPHIC 530766
6 GRAPHIC g593778ex99_2s3g1.jpg GRAPHIC 282159
7 GRAPHIC g593778ex99_2s4g1.jpg GRAPHIC 310188
8 GRAPHIC g593778ex99_2s5g1.jpg GRAPHIC 214362
9 GRAPHIC g593778ex99_2s6g1.jpg GRAPHIC 310490
10 GRAPHIC g593778ex99_2s7g1.jpg GRAPHIC 269162
11 GRAPHIC g593778ex99_2s8g1.jpg GRAPHIC 160537
12 GRAPHIC g593778img1.jpg GRAPHIC 7130
  Complete submission text file 0001193125-18-171457.txt   3128881
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 18854124
SIC: 2834 Pharmaceutical Preparations